Dr Jason Boland

Dr Jason Boland

Senior Clinical Lecturer and Honorary Consultant in Palliative Medicine

Faculty and Department

  • Faculty of Health Sciences
  • Hull York Medical School

Summary

Jason Boland is a senior clinical lecturer and honorary consultant in palliative medicine at Hull & York Medical School and North East Lincolnshire. He qualified in medicine from the University of Cambridge in 1999, with an MA in neuroscience. He completed his higher specialist training in palliative medicine in Sheffield, where for his PhD he performed a systematic analysis of the in vitro effect of opioids on adaptive and innate immune function. He is collaborating on a European trial to evaluate the effect of opioids on immune and endocrine function in opioid naive patients randomised to receive weak or strong opioids.

His interests include understanding the molecular actions of opioids and how to maximise their efficacy while minimising toxicity as well as development and improvement of the delivery of palliative care. He is currently researching the effect of opioids on immune, endocrine, gastrointestinal and cognitive function, and is also involved in non-malignant lung disease research. He lectures nationally and internationally on these topics. He is on the sub-committee of an international pharmacovigilance audit which is assessing the benefits and toxicity of Haloperidol for Nausea. He is developing palliative care research in NE Lincolnshire where he is currently the PI on 2 portfolio studies.

He is the elected Chair of the Science Committee of the Association for Palliative Medicine (UK and Ireland) as well as being on their Executive Committee. He is on the organising committee for the palliative care congress and Association for Palliative Medicine conference; and leads on organising their research study days. He is an NIHR Dissemination Centre panel of expertcommentator. He is on the gastrointestinal subgroup and Early Stage and Acute Toxicities Subgroup of the NCRI Supportive & Palliative Care CSG, and on the Steering Group for NIHR Themed Review on End of Life Care. He is an associate editor for BMJ Supportive and Palliative Care and is on the editorial board for the journal Palliative Medicine and for the Palliative Care Formulary. He is the editor for a evidence update blog for the BMJ Supportive & Palliative Care Journal.

He regularly delivers undergraduate and postgraduate teaching, including SSCs/SSIPs, and is involved in reviewing and reshaping the palliative medicine curriculum in Hull York Medical School. He is the academic lead for palliative medicine and led the cancer block. He recently won the Postgraduates' Choice Award for the University of Hull’s Student-Led Teaching Awards and was a finalist in the Hull York Medical School 2016 phase 2/3 awards.

Membership:

Board of Studies

Phase II & III Curriculum Management Group

Academic lead for palliative care:

Attained new HEE funding for increased delivery of specialist palliative care across Hull York Medical School

After completing a full mapping process of palliative care undergraduate teaching in Hull York Medical School we have developed general palliative care as a parallel theme across all medical and surgical attachments.

Developing learning objectives for this theme

Developing a specialist palliative care attachment across Hull York Medical School

Curriculum review and implementation for general and specialist palliative care

Metabolic medicine block lead:

Coordination of block, including exam question writing

Exam question selection

Question writing

Exam marking and moderating

I was lead for the cancer block, developing Blackboard, online resources and a Hull York Medical School-wide radiotherapy study day, and have been central to cancer and general palliative care becoming a longitudinal theme across phase 2.

Undergraduate exams:

Block 17 Exam question writing and reviewing - MCQs, MEQs and EMQs.

Writing e-learning exam questions

Phase 1, 2 and 3 Standard setting

Phase 1, 2 and 3 exam marking

Phase 1, 2 and 3 examination paper reviews

Phase 1, 2 and 3 Board of Examiners meeting

Communication masterclasses:

Delivered and led phase II and III communication masterclasses

Built up a base of tutors on the south bank, now developing other areas

Undergraduate lectures:

Plenary lectures, phase 1 block 13 – palliative care service provision

Plenary lectures, phase 2 - Pain PPT

Phase 1 spiritual issues in end of life care – single site interactive lecture

HYMS year 4 critical appraisal revision sessions

Undergraduate cancer block 17 teaching phase 2:

Development of the NE Lincolnshire undergraduate palliative medicine teaching

Delivery of case review sessions to the medical students

Delivery of lectures to the medical students

Increased students time in hospice

DNACPR and breaking bad news teaching

Hull York Medical School Elective student (part placement in Grimsby)

Mentor for 8 phase 2 students.

SSC/SSIP:

Developed and delivered a phase 1 SSC to introduce students to palliative medicine and its principals

Developed and led on a phase 2 SSC in Grimsby (4 students, 3 times a year) to further students clinical understanding of palliative medicine

Setup, led, developed and delivered a phase 1 palliative medicine SSIP

Setup, led, developed and delivered a phase 2 palliative medicine SSIP

Non-Hull York Medical School:

Deliver metabolic derangement and clinical scenarios in cachexia lectures on post-graduate MSc

Question writing and marking for MSc in nutrition exam

Palliative care lectures to MSc in Translational Oncology

Question writing for MSc in Translational Oncology exam

Recent outputs

View more outputs

Journal Article

Development of a Core Outcome Set for the research and assessment of malignant bowel obstruction

Bravington, A., Obita, G., Baddeley, E., Johnson, M., Murtagh, F., Currow, D., …Boland, J. (2023). Development of a Core Outcome Set for the research and assessment of malignant bowel obstruction. PLoS ONE, 18(8), Article e0289501. https://doi.org/10.1371/journal.pone.0289501

Non-pharmacological interventions to manage psychological distress in patients living with cancer: a systematic review

Paley, C. A., Boland, J. W., Santarelli, M., Murtagh, F. E., Ziegler, L., & Chapman, E. J. (2023). Non-pharmacological interventions to manage psychological distress in patients living with cancer: a systematic review. BMC Palliative Care, 22(1), Article 88. https://doi.org/10.1186/s12904-023-01202-8

Effects of Opioids on Immune and Endocrine Function in Patients with Cancer Pain

Bradley, A., & Boland, J. W. (2023). Effects of Opioids on Immune and Endocrine Function in Patients with Cancer Pain. Current Treatment Options in Oncology, 24(7), 867-879. https://doi.org/10.1007/s11864-023-01091-2

High-quality phase 3 studies do not support the use of somatostatin analogues to reduce vomiting in malignant bowel obstruction

Boland, J. W., Boland, E. G., & Currow, D. C. (2023). High-quality phase 3 studies do not support the use of somatostatin analogues to reduce vomiting in malignant bowel obstruction. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 31(4), Article 211. https://doi.org/10.1007/s00520-023-07669-8

Over a third of palliative medicine physicians meet burnout criteria: Results from a survey study during the COVID-19 pandemic

Boland, J. W., Kabir, M., Spilg, E. G., Webber, C., Bush, S. H., Murtagh, F., & Lawlor, P. G. (2023). Over a third of palliative medicine physicians meet burnout criteria: Results from a survey study during the COVID-19 pandemic. Palliative medicine, 37(3), 343-354. https://doi.org/10.1177/02692163231153067

Research interests

I have set up and am developing NE Lincolnshire as a palliative medicine research site:

I've been awarded £22,482 a year over the past 2 years by the NIHR clinical research network for a research nurse

PI for Improving Rehabilitation in Palliative care using Goal Attainment Scaling (GAS) - portfolio study

PI for Improving the Management of pain from advanced cancer in the Community (IMPACCT) - portfolio study

PI for The Prognosis in Palliative care Study (PiPS2) - portfolio study

PI for Self-Management of Analgesia and Related Treatments at the End of life portfolio study (pilot site)

PI for carers needs study - portfolio study

PI on CRN portfolio study to assess the impact of opioid induced constipation on patients - portfolio study

In Hull, I am PI for The Palliative Radiotherapy And Inflammation Study (PRAIS) and Validation of a palliative needs assessment tool in ILD (NA-ILD) study - portfolio studies.

I am currently collaborating with Prof Fallon in Edinburgh, who is leading on a study assessing the immune and endocrine function in patients with cancer commencing opioids.

I am collaborating with Prof Johnson and colleagues in London and Manchester to develop a tool to assess needs in patients with interstitial lung disease. CRUK Marie Curie £117,462.

CI on a qualitative study to explore palliative care nurses perceptions of the multiprofessional education of medical students.

CI on a qualitative study using reflective essays to explore medical students perceptions of palliative care patients.

Developing translational immunology studies to assess the pre-clinical impact of early palliative care in NSCLC.

NIHR Comprehensive Clinical Research Network research Clinical Lead for NE Lincolnshire Community.

I have been awarded £19,958 by Macmillan via Hull Churches Home from Hospital Service to evaluate and develop a training and support package for their Families together project.

I am the CI on 2 qualitative education projects, including an international one exploring palliative care nurses perceptions of the multiprofessional education of medical students.

Grants

Co-PI with Prof Noble (Cardiff). Marie Curie £177,489. RAMBO: Research Assessment Outcome Measures for Malignant Bowel Obstruction. 2018-2020.

Co-applicant, Lead Prof Bennett (Leeds) and Prof Yorkshire Cancer Research £1,369,806. RESOLVE: Improving Health Status and Experience of Pain and other Symptoms for People with Advanced Cancer. 2018-2022.

Co-applicant, Lead Prof Macleod. Yorkshire Cancer Research; £4,942,336. TRANSFORM: Reducing inequalities in cancer outcomes in Yorkshire: Realising our potential for innovation in diagnosis, patient management, survivorship and palliative care research. 2017-2022.

Co-applicant for Wolfson palliative care centre bid. Wolfson Foundation, lead – Prof Johnson. £500,000 – 2016

Lead applicant. National Institute for Health Research clinical research network £22,482. Research nurse. 2016

Site PI. Lead Prof Bennett (Leeds). Hull awarded £2,000. IMPACCT: Improving the Management of Pain from Advanced Cancer in the Community Implementation Feasibility Randomised Controlled Trial. 2017-2019.

Lead applicant. Health Education Yorkshire and the Humber £16,000. Yorkshire generalist palliative care guidelines. 2015-2019.

Co-applicant. Lead – Prof Johnson. Marie curie, £117,454. NAT ILD: The Adaption and Validation Of An Assessment Tool To Identify The Palliative Care Needs Of People With Irreversible Idiopathic Interstitial Lung Disease For Use In Every Day Clinical Practice. 2014-2016.

Principal Investigator. Macmillan £19,958. Hull churches Families Together Evaluation. 2014-2017

Co-investigator

Project

Funder

Grant

Started

Status

Project

TRANSFORM: Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research

Funder

YCR Yorkshire Cancer Research

Grant

£1,806,650.00

Started

1 September 2017

Status

Ongoing

Project

TRANSFORM: Improving shared decision-making in malignant bowel obstruction: An exploration of context-specific treatment pathways and experiences to inform intervention development for person-centred care

Funder

YCR Yorkshire Cancer Research

Grant

£210,701.00

Started

1 September 2021

Status

Ongoing

Project

RESOLVE: Improving Health Status and Experience of Pain and other Symptoms for People with Advanced Cancer

Funder

YCR Yorkshire Cancer Research

Grant

£623,225.00

Started

1 June 2018

Status

Complete

Top